Showing results (51-60 of 327) with videos related to
Sort By:
Pageof 33
Thorax|February 1, 1992
Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasisP Lloberes, E Montserrat, J M Montserrat, et al.Cancer Treatment Reports|May 1, 1986
Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustineF Cervantes, J C Reverter, E Montserrat, et al.Human Genetics|December 15, 1976
Hereditary hemolytic anemia with erythrocyte pyrimidine 5'-nucleotidase deficiency in Spain. Clinical, biological and familial studiesJ L Vives-Corrons, E Montserrat-Costa, C RozmanNouvelle Revue Francaise D'Hematologie|January 1, 1988
Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stagesE Montserrat, N Viñolas, J C Reverter, et al.British Journal of Haematology|March 1, 1986
Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significanceE Montserrat, J Sanchez-Bisono, N Viñolas, et al.European Journal of Haematology|May 1, 1990
Timing of diagnosis and lymphocyte accumulation patterns in chronic lymphocytic leukemia: analysis of their clinical significanceS Molica, J C Reverter, A Alberti, et al.Leukemia|October 3, 2002
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemiaN Gupta, S Kavuru, D Patel, et al.Sangre|October 1, 1990
[Effect of the administration of rhGM-CSF in a patient with marrow aplasia resistant to immunosuppressive treatment]P Marín, M Rovira, C Sanz, et al.Leukemia & Lymphoma|July 28, 2016
Efficacy of ABVD Therapy in Resistant Hodgkin's DiseaseE Montserrat, J M Martí, J C Reverter, et al.Medicina Clinica|January 21, 1989
[Analysis of response to treatment. Considerations on changing prognostic variables (time-dependent)]C Rozman, E Montserrat, M Rozman, et al.Pageof 33